Large-scale functional network connectivity mediates the associations between lipids metabolism and cognition in type 2 diabetes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: SAGE Publications Country of Publication: United States NLM ID: 8112566 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-7016 (Electronic) Linking ISSN: 0271678X NLM ISO Abbreviation: J Cereb Blood Flow Metab Subsets: MEDLINE
    • Publication Information:
      Publication: 2016- : Thousand Oaks, CA : SAGE Publications
      Original Publication: New York : Raven Press, c1981-
    • Subject Terms:
    • Abstract:
      Type 2 diabetes (T2D) is associated with dyslipidemia and mild cognitive impairment. This study investigated the relationships between serum lipids metabolism, cognition, and functional connectivity (FC) within and between brain networks in T2D patients. The study included 102 T2D patients and 45 healthy controls who underwent functional magnetic resonance imaging, lipid profile tests, and cognitive assessments. Thirteen functional networks were identified using independent component analysis. The statistical analyses included multivariate analysis of covariance, partial correlation, canonical correlation, and mediation analyses. We found widely reduced between-network FCs in T2D, especially between the ventral sensorimotor network (SMN) and dorsal attention network (DAN) (p = 0.001) and between the ventral SMN and lateral visual network (VN) (p < 0.001). Moreover, lower between-network FCs were correlated with worse serum lipids metabolism and poorer cognitive performance (all p < 0.05). Importantly, between-network FCs mediated the relationship between lipid metabolism and cognition (β = -0.3136, 95% CI: -0.7660, -0.0186). Within-network analyses revealed altered FCs within the anterior default mode network, DAN, and lateral VN, each positively correlated with global cognition (all p < 0.01). Our results suggest the potential of improving cognitive function by regulating serum lipids in individuals with T2D.
      Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
    • References:
      Alzheimers Dement. 2018 Feb;14(2):167-177. (PMID: 28916238)
      Science. 2013 Nov 1;342(6158):1238411. (PMID: 24179229)
      Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13040-5. (PMID: 19620724)
      Lancet Diabetes Endocrinol. 2020 Jun;8(6):535-545. (PMID: 32445740)
      Diabetes Care. 2013 Jan;36(1):90-7. (PMID: 22933440)
      Age Ageing. 2012 Sep;41(5):600-6. (PMID: 22447910)
      Nat Rev Neurosci. 2019 Jul;20(7):435-446. (PMID: 31127193)
      Neurosci Lett. 2010 Mar 31;473(1):5-10. (PMID: 20123114)
      J Diabetes Investig. 2019 Jan;10(1):139-146. (PMID: 29777621)
      Neural Plast. 2020 Nov 1;2020:8894868. (PMID: 33204252)
      Brain Imaging Behav. 2019 Dec;13(6):1699-1707. (PMID: 30612339)
      Radiology. 2014 Jul;272(1):29-49. (PMID: 24956047)
      Front Hum Neurosci. 2021 Dec 24;15:796386. (PMID: 35002661)
      Front Aging Neurosci. 2020 Jul 22;12:223. (PMID: 32848704)
      Diabetes. 2012 Sep;61(9):2375-9. (PMID: 22664957)
      Neurology. 2015 Jun 9;84(23):2329-37. (PMID: 25948725)
      Trends Cogn Sci. 2011 Oct;15(10):483-506. (PMID: 21908230)
      Diabetes. 2014 Feb;63(2):728-38. (PMID: 24203723)
      Circulation. 2021 May 18;143(20):1949-1961. (PMID: 33966448)
      Neuroimage. 2007 Aug 1;37(1):343-60. (PMID: 17553704)
      Nat Rev Neurosci. 2015 Mar;16(3):159-72. (PMID: 25697159)
      Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13848-53. (PMID: 16945915)
      Front Aging Neurosci. 2015 Dec 11;7:233. (PMID: 26696885)
      Front Neuroendocrinol. 2017 Oct;47:34-46. (PMID: 28687473)
      Neuron. 2006 Oct 5;52(1):155-68. (PMID: 17015233)
      Annu Rev Neurosci. 2015 Jul 8;38:433-47. (PMID: 25938726)
      Neuron. 2011 Nov 17;72(4):665-78. (PMID: 22099467)
      J Gerontol A Biol Sci Med Sci. 2023 Mar 1;78(3):521-526. (PMID: 36124711)
      J Clin Endocrinol Metab. 2019 Jul 1;104(7):3025-3038. (PMID: 30817818)
      Neuroimage. 2007 Oct 15;38(1):95-113. (PMID: 17761438)
      Nat Commun. 2021 Apr 23;12(1):2408. (PMID: 33893307)
      Lancet Neurol. 2023 Jul;22(7):602-618. (PMID: 37236211)
      Lipids Health Dis. 2015 May 21;14:47. (PMID: 25989796)
      Neuroradiology. 2019 Jun;61(6):703-710. (PMID: 31011773)
      Diabetologia. 2020 Jan;63(1):3-9. (PMID: 31420699)
      J Alzheimers Dis. 2015;50(2):455-63. (PMID: 26682694)
      JAMA Neurol. 2014 Feb;71(2):195-200. (PMID: 24378418)
      Curr Alzheimer Res. 2017;14(11):1238-1246. (PMID: 28413981)
      J Clin Lipidol. 2016 Jan-Feb;10(1):150-60. (PMID: 26892132)
      AJNR Am J Neuroradiol. 2016 Nov;37(11):2115-2122. (PMID: 27365332)
      Hum Brain Mapp. 2001 Nov;14(3):140-51. (PMID: 11559959)
      Ann N Y Acad Sci. 2008 Mar;1124:1-38. (PMID: 18400922)
      Metab Brain Dis. 2019 Apr;34(2):477-484. (PMID: 30649667)
      Neuroimage. 2012 Feb 1;59(3):2142-54. (PMID: 22019881)
      Lancet Diabetes Endocrinol. 2020 Apr;8(4):325-336. (PMID: 32135131)
      Sci Rep. 2015 Jun 08;5:11148. (PMID: 26053355)
      Eur Radiol. 2015 Nov;25(11):3238-46. (PMID: 25903712)
    • Contributed Indexing:
      Keywords: Type 2 diabetes; cognitive impairment; functional connectivity; large-scale brain networks; lipid profile
    • Accession Number:
      0 (Lipids)
    • Publication Date:
      Date Created: 20231005 Date Completed: 20240216 Latest Revision: 20240320
    • Publication Date:
      20240320
    • Accession Number:
      PMC10870959
    • Accession Number:
      10.1177/0271678X231204426
    • Accession Number:
      37795619